fast
untrac
viru
mutat
take
live
thousand
peopl
immun
system
produc
inhibitori
antibodi
recent
outbreak
novel
coronaviru
infect
kill
thousand
peopl
world
rapid
method
find
peptid
antibodi
sequenc
inhibit
viral
epitop
save
life
thousand
paper
devis
machin
learn
ml
model
predict
possibl
inhibitori
synthet
antibodi
corona
viru
collect
virusantibodi
sequenc
clinic
patient
neutral
respons
train
ml
model
predict
antibodi
respons
use
graph
featur
varieti
ml
method
screen
thousand
hypothet
antibodi
sequenc
found
stabl
antibodi
potenti
inhibit
combin
bioinformat
structur
biolog
molecular
dynam
md
simul
verifi
stabil
candid
antibodi
inhibit
corona
viru
keyword
coronaviru
machin
learn
antibodi
engin
bioinformat
biomolecular
process
recognit
neutral
viral
particl
process
viral
antigen
present
recruit
appropri
b
cell
synthes
neutral
antibodi
theoret
process
allow
immun
system
stop
viral
invas
respons
slow
often
requir
day
even
week
adequ
immun
respons
achiev
pose
challeng
question
process
antibodi
discoveri
acceler
counter
highli
infect
viral
diseas
rapid
expans
avail
biolog
data
dnaprotein
sequenc
structur
possibl
model
predict
complex
biolog
phenomena
machin
learn
ml
approach
given
suffici
train
data
ml
use
learn
map
viral
epitop
effect
complementari
antibodi
map
learnt
use
predict
potenti
neutral
antibodi
given
viral
sequenc
ml
essenti
learn
complex
antigenantibodi
interact
faster
human
immun
system
lead
gener
synthet
inhibitori
antibodi
act
bridg
overcom
latenc
viral
infect
human
immun
system
respons
bridg
potenti
save
life
mani
especi
outbreak
pandem
one
instanc
spread
coronaviru
diseas
covid
incred
high
infect
mortal
rate
becom
global
scare
compound
problem
proven
therapeut
aid
suffer
patient
viabl
treatment
moment
symptomat
desper
need
develop
therapeut
counter
recent
proteom
sequenc
whhuman
coronaviru
becam
avail
metagenom
rna
sequenc
patient
wuhan
whhuman
similar
group
sarslik
coronavirus
sequenc
avail
possibl
find
potenti
inhibitori
antibodi
scan
thousand
antibodi
sequenc
discov
neutral
one
howev
requir
expens
timeconsum
experiment
discov
inhibitori
respons
corona
viru
time
manner
addit
comput
physicsbas
model
requir
bound
crystal
structur
antibodyantigen
complex
howev
structur
becom
avail
case
bound
antigenantibodi
crystal
structur
avail
todat
given
challeng
fact
ml
model
requir
larg
amount
data
ml
approach
reli
sequenc
antibodyantigen
rather
crystal
structur
paper
collect
dataset
compris
antibodyantigen
sequenc
varieti
virus
includ
hiv
influenza
dengu
sar
ebola
hepat
etc
patient
clinicalbiochem
data
use
dataset
call
virusnet
train
benchmark
differ
shallow
deep
ml
model
select
best
perform
model
base
sar
neutral
antibodi
scaffold
creat
thousand
potenti
antibodi
candid
mutat
screen
best
perform
ml
model
final
molecular
dynam
md
simul
perform
neutral
candid
check
structur
stabil
predict
structur
stabl
cours
simul
potenti
neutral
antibodi
addit
interpret
ml
method
understand
alter
sequenc
bind
region
antibodi
would
effect
counter
viral
mutat
restor
abil
antibodi
bind
viru
inform
critic
term
antibodi
design
engin
reduc
dimens
combinator
mutat
need
find
neutral
antibodi
major
data
train
set
compos
hiv
antibodyantigen
complex
sampl
sampl
hiv
train
set
obtain
compil
analyz
talli
nab
panel
catnap
databas
lo
alamo
nation
laboratori
lanl
catnap
data
collect
monoclon
antibodi
bind
use
catnap
function
identifi
epitop
align
select
fasta
sequenc
antigen
correspond
site
align
antibodi
make
dataset
divers
train
robust
ml
model
includ
avail
antibodyantigen
sequenc
neutral
potenti
compil
sequenc
influenza
dengu
ebola
sar
hepat
etc
search
keyword
viru
antibodi
rcsb
server
select
neutral
complex
read
correspond
public
furthermor
neutral
complex
contact
residu
interfac
antibodi
antigen
select
select
antigen
contact
sequenc
amino
acid
within
correspond
antibodi
chosen
support
inform
select
antibodi
contact
sequenc
amino
acid
within
antigen
chosen
total
sequenc
antibodyantigen
complex
mine
ad
sampl
result
total
number
train
sampl
effect
represent
molecular
structur
amino
acid
individu
atom
amino
acid
antibodi
antigen
treat
undirect
graph
atom
node
bond
edg
shown
graph
represent
better
transfer
chemistri
topolog
molecular
structur
compar
extend
connect
fingerprint
ecfp
construct
molecular
graph
use
rdkit
embed
gener
encod
relev
featur
molecular
graph
embed
encod
inform
like
type
atom
valenc
atom
hybrid
state
aromat
etc
first
antibodi
antigen
encod
separ
embed
concaten
singl
embed
entir
antibodyantigen
complex
appli
mean
pool
featur
concaten
embed
ensur
dimension
consist
across
train
data
pool
inform
pass
classifi
algorithm
like
xgboost
random
forest
multilay
perceptron
support
vector
machin
svm
logist
regress
predict
whether
antibodi
capabl
neutral
viru
order
find
potenti
antibodi
candid
differ
mutant
strain
antibodi
sequenc
gener
base
sequenc
sar
neutral
antibodi
reason
select
antibodi
initi
scaffold
genom
ident
isol
sar
access
number
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
amino
acid
bind
region
antibodi
see
support
inform
antigen
antibodi
interact
find
bind
region
antibodi
sequenc
gener
amino
acid
within
respect
antigen
chosen
assess
biolog
feasibl
mutant
sequenc
score
mutat
use
matrix
assess
stabil
propos
antibodi
structur
perform
molecular
dynam
md
simul
antibodi
structur
solvat
environ
simul
solvat
antibodi
carri
use
topolog
antibodi
gener
accord
gromo
forcefield
protein
center
box
extend
nanomet
surfac
protein
box
solvat
model
water
atom
preequilibr
antibodi
system
gener
carri
net
posit
charg
neutral
counter
ion
energi
minim
carri
use
steepest
descent
algorithm
restrain
peptid
backbon
remov
steric
clash
atom
subsequ
optim
solvent
molecul
geometri
cutoff
distanc
criteria
minim
forc
less
kjmolnm
number
step
exceed
minim
structur
sent
two
round
equilibr
first
nvt
ensembl
picosecond
time
step
leapfrog
dynam
integr
use
verlet
scheme
neighborlist
updat
everi
step
ensembl
period
boundari
condit
harmon
constraint
appli
linc
algorithm
scheme
longrang
electrostat
interact
comput
particl
mesh
ewald
pme
algorithm
berendsen
thermostat
use
temperatur
coupl
pressur
coupl
done
use
parrinello
ccbyncnd
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
rahman
barostat
last
round
npt
simul
ensur
simul
system
physiolog
temperatur
pressur
system
volum
free
chang
npt
ensembl
fact
chang
significantli
cours
simul
follow
round
equilibr
product
run
system
carri
npt
constraint
total
nanosecond
ident
simul
paramet
flowchart
antibodi
discoveri
use
ml
four
major
step
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
test
follow
influenza
dengu
ebola
hepat
sar
class
result
demonstr
model
capabl
gener
predict
complet
novel
viru
epitop
sinc
complet
new
viru
conclud
model
predict
perform
accur
fact
model
predict
sar
class
test
demonstr
capabl
effect
predict
antibodi
sar
famili
order
comprehens
creat
comut
stabl
point
mutat
see
tabl
support
inform
list
candid
result
ccbyncnd
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
new
structur
tabl
screen
use
xgboost
neutral
among
comut
neutral
check
stabil
neutral
comut
md
simul
perform
found
stabl
figur
list
final
stabl
mutat
comut
tabul
tabl
pdb
structur
avail
support
inform
develop
machin
learn
model
high
throughput
screen
synthet
antibodi
discov
antibodi
potenti
inhibit
approach
wide
appli
virus
sequenc
viral
coat
proteinantibodi
pair
obtain
ml
model
train
differ
viru
type
achiev
fivefold
test
accuraci
class
predict
sar
influenza
demonstr
power
model
neutral
predict
antibodi
novel
virus
like
use
model
neutral
thousand
hypothet
antibodi
predict
antibodi
found
highli
effici
neutral
use
md
simul
stabil
predict
antibodi
check
stabl
antibodi
found
neutral
addit
interpret
ml
model
reveal
mutat
methionin
tyrosin
highli
effici
enhanc
affin
antibodi
ccbyncnd
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
jayan
support
junhan
li
help
collect
data
rmsd
contact
distanc
plot
trajectori
versu
time
structur
viru
antibodi
complex
residu
contact
region
nativ
contact
antigenantibodi
complex
interact
epitop
antibodi
tabl
neutral
point
mutat
comut
neutral
potenti
structur
stabl
antibodi
pdb
format
data
interpret
avail
onlin
virusnet
dataset
avail
upon
request
ccbyncnd
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
figur
design
antibodi
peptid
sequenc
inhibit
viru
requir
high
throughput
experiment
vastli
mutat
sequenc
potenti
inhibitor
screen
thousand
avail
strain
antibodi
prohibit
expens
feasibl
due
lack
avail
structur
howev
machin
learn
model
enabl
rapid
inexpens
explor
vast
sequenc
space
comput
fraction
second
collect
virusantibodi
sequenc
clinic
patient
data
graph
featur
antibodyantigen
sequenc
creat
uniqu
molecular
represent
use
graph
represent
benchmark
use
varieti
shallow
deep
learn
model
select
xgboost
superior
perform
interpret
train
model
use
dataset
includ
divers
viru
epitop
antibodi
gener
hypothet
antibodi
librari
mutat
sar
scaffold
antibodi
gener
thousand
possibl
candid
use
ml
model
classifi
sequenc
select
top
sequenc
neutral
high
confid
use
md
simul
check
stabil
sequenc
rank
base
stabil
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
figur
test
accuraci
fivefold
cross
valid
xgboost
random
forrest
rf
logist
regress
lr
support
vector
machin
svm
deep
learn
multilay
perceptron
xgboost
highest
perform
b
train
class
test
accuraci
influenza
dengu
ebola
hepat
sar
perform
test
exampl
influenza
influenza
virusantibodi
sequenc
remov
train
set
obtain
model
test
sampl
influenza
accuraci
report
c
blossum
valid
mutat
nonneutr
neutral
antibodi
sequenc
achiev
confid
set
threshold
predict
probabl
xgboost
found
neutral
antibodi
sequenc
green
point
interpret
ml
model
understand
mutat
play
key
role
neutral
xgboost
featur
import
use
rank
atom
level
featur
connect
atom
featur
amino
acid
found
import
amino
acid
neutral
follow
f
w
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
ccbyncnd
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
